RE
BIIB icon

RBC Europe’s Biogen BIIB Stock Holding History

RBC Europe’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$340K Buy
1,668
+66
+4% +$13.5K 0.02% 166
2022
Q1 		$337K Hold
1,602
– – 0.01% 180
2021
Q4 		$384K Sell
1,602
-862
-35% -$222K 0.02% 169
2021
Q3 		$697K Hold
2,464
– – 0.03% 171
2021
Q2 		$853K Sell
2,464
-40
-2% -$12.1K 0.04% 155
2021
Q1 		$700K Buy
2,504
+357
+17% +$96.3K 0.04% 164
2020
Q4 		$526K Buy
2,147
+216
+11% +$55.7K 0.03% 174
2020
Q3 		$548K Sell
1,931
-20
-1% -$5.58K 0.04% 164
2020
Q2 		$522K Sell
1,951
-461
-19% -$139K 0.04% 158
2020
Q1 		$763K Buy
2,412
+663
+38% +$201K 0.08% 117
2019
Q4 		$519K Sell
1,749
-34
-2% -$9.43K 0.05% 160
2019
Q3 		$415K Sell
1,783
-25
-1% -$5.82K 0.04% 172
2019
Q2 		$423K Hold
1,808
– – 0.04% 169
2019
Q1 		$427K Hold
1,808
– – 0.05% 160
2018
Q4 		$544K Hold
1,808
– – 0.07% 142
2018
Q3 		$639K Sell
1,808
-50
-3% -$17.2K 0.07% 138
2018
Q2 		$539K Sell
1,858
-55
-3% -$15.5K 0.06% 151
2018
Q1 		$524K Sell
1,913
-111
-5% -$34.5K 0.06% 150
2017
Q4 		$645K Buy
2,024
+63
+3% +$20.2K 0.08% 135
2017
Q3 		$614K Buy
+1,961
New +$581K 0.08% 137

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

RBC Europe's BIIB Position: Q2 2022 in Review

RBC Europe increased its Biogen (BIIB) stake by 4.1% in Q2 2022, buying an estimated $13.5K and bringing the position to 1,668 shares worth $340K. The position accounts for 0.02% of the portfolio, ranked #166.

RBC Europe first reported a position in BIIB in Q3 2017 and has held it in 20 quarters since. The position peaked at $853K in Q2 2021. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • RBC Europe held 1,668 shares of Biogen worth $340K as of Q2 2022.
  • RBC Europe bought 66 Biogen shares in Q2 2022, an estimated $13.5K.
  • Biogen made up 0.02% of RBC Europe's portfolio in Q2 2022, its #166 holding.
  • RBC Europe first reported a position in Biogen in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Biogen position peaked at $853K in Q2 2021.
  • 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.